In the German edition of Legal 500 2017 Maiwald is again ranked as one of the leading practices in the field of patent prosecution. “The ‘very strong team’ is recommended for ‘its fast and thorough methodology’ as well as for “cost-effective and efficient solutions”, write the editors. “Pharmacy and chemistry are the strongest areas, where numerous large international corporations belong to the client base, although the areas of biology and biotechnology as well as physics, engineering and electrical engineering are also covered.” Dr Dirk Bühler and Dr Eva Ehlich are recommended for official proceedings in the field of Life Sciences. On the issue of dispute resolution, Legal 500 Deutschland emphasizes that while Maiwald “is primarily active in the IP segment, it is becoming increasingly recommended for its activities in relation to legal aspects of patent litigation, especially with reference to pharma patents.” The Munich team of Marco Stief excels through “outstanding industry knowledge”, works “very fast and flexibly” and is valued for its “very good price-performance ratio”.
All awards
